The Implementation of New Therapies for Severe Sepsis: Some Questions Raised by "Early Goal-directed Therapy, Corticosteroid, and Recombinant Human Activated Protein C for the Treatment of Severe Sepsis and Septic Shock in the Emergency Department"
Early goal-directed therapy, corticosteroid, and recombinant human activated protein C for the treatment of severe sepsis and septic shock in the emergency department
Nguyen H.B., Corbett S.W., Menes K., et al. Early goal-directed therapy, corticosteroid, and recombinant human activated protein C for the treatment of severe sepsis and septic shock in the emergency department. Acad Emerg Med 13 (2006) 109-113
Efficacy and safety of recombinant human activated protein C for severe sepsis
Bernard G.R., Vincent J.L., Laterre P.F., et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344 (2001) 699-709
Early goal-directed therapy in the treatment of severe sepsis and septic shock
Rivers E., Nguyen B., Havstad S., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345 (2001) 1368-1377
Drotrecogin alfa packet insert. Eli Lilly & Company. Indianapolis, IN. 2005.
5
12944323168
Induced hypothermia is underused after resuscitation from cardiac arrest: a current practice survey
Abella B.S., Rhee J.W., Huang K.N., et al. Induced hypothermia is underused after resuscitation from cardiac arrest: a current practice survey. Resuscitation 64 (2005) 181-186
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger R.P., Carlet J.M., Masur H., et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32 (2004) 858-873
Use of goal-directed therapy for severe sepsis and septic shock in academic emergency departments
Jones A.E., and Kline J.A. Use of goal-directed therapy for severe sepsis and septic shock in academic emergency departments. Crit Care Med 33 (2005) 1888-1889
A national evaluation of the effect of trauma-center care on mortality
MacKenzie E.J., Rivara F.P., Jurkovich G.J., et al. A national evaluation of the effect of trauma-center care on mortality. N Engl J Med 354 (2006) 366-378
Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group
The National Institute of Neurological Disorders and Stroke. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 333 (1995) 1581-1587
